Company intelligence / Profile preview

Asahi Breweries

Sumida-ku, Tokyo, Japanasahiinternational.com ↗

Ownership: Private
Employees: ~30000
Development stage: Other

Overview

Asahi Group Holdings leads Japan’s beer market and has expanded globally through major acquisitions. In recent years, it has diversified into health and wellness with research-backed functional ingredients like Lactobacillus gasseri CP2305 for stress/menopause support and yeast mannan for gut/sleep benefits. These are commercialized mainly as supplements or functional drinks in Japan.

No pharmaceutical clinical pipeline exists.

Therapeutic areas: PsychiatryGastroenterologyNeurologyWomen's Health
Modalities: Probiotic-based productPrebiotic-based product
Industry: Food & Nutrition

Partnerships

ADM Wild Valencia for international sales of probiotic ingredient CP2305

Beyond the preview

Go deeper on Asahi Breweries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asahi Breweries.

Explore the full profile